- Home
- FOSL vs KZR Comparison
FOSL vs KZR Comparison
Compare FOSL & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOSL
- KZR
- Stock Information
- Founded
- FOSL 1984
- KZR 2015
- Country
- FOSL United States
- KZR United States
- Employees
- FOSL N/A
- KZR N/A
- Industry
- FOSL Consumer Specialties
- KZR Biotechnology: Pharmaceutical Preparations
- Sector
- FOSL Consumer Discretionary
- KZR Health Care
- Exchange
- FOSL Nasdaq
- KZR Nasdaq
- Market Cap
- FOSL 55.3M
- KZR 65.3M
- IPO Year
- FOSL 1993
- KZR 2018
- Fundamental
- Price
- FOSL $1.15
- KZR $7.54
- Analyst Decision
- FOSL
- KZR Hold
- Analyst Count
- FOSL 0
- KZR 2
- Target Price
- FOSL N/A
- KZR $20.00
- AVG Volume (30 Days)
- FOSL 432.2K
- KZR 72.5K
- Earning Date
- FOSL 11-07-2024
- KZR 11-12-2024
- Dividend Yield
- FOSL N/A
- KZR N/A
- EPS Growth
- FOSL N/A
- KZR N/A
- EPS
- FOSL N/A
- KZR N/A
- Revenue
- FOSL $1,223,954,000.00
- KZR N/A
- Revenue This Year
- FOSL N/A
- KZR N/A
- Revenue Next Year
- FOSL N/A
- KZR $66.68
- P/E Ratio
- FOSL N/A
- KZR N/A
- Revenue Growth
- FOSL N/A
- KZR N/A
- 52 Week Low
- FOSL $0.75
- KZR $5.20
- 52 Week High
- FOSL $1.74
- KZR $11.40
- Technical
- Relative Strength Index (RSI)
- FOSL 44.44
- KZR 49.95
- Support Level
- FOSL $1.02
- KZR $7.21
- Resistance Level
- FOSL $1.36
- KZR $7.65
- Average True Range (ATR)
- FOSL 0.12
- KZR 0.24
- MACD
- FOSL -0.02
- KZR -0.01
- Stochastic Oscillator
- FOSL 37.23
- KZR 76.56
About FOSL Fossil Group Inc.
Fossil Group Inc is a design, innovation and distribution company in consumer fashion accessories. The products include traditional watches, smartwatches, jewelry, handbags, small leather goods, belts and sunglasses. The reportable segments are comprised of 1) Americas segment includes sales in Canada, Latin America and the United States. 2) Europe segment includes sales in European countries, the Middle East and Africa. 3) Asia segment includes sales in Australia, China, India, Indonesia, Japan, Malaysia, New Zealand, Singapore, South Korea and Thailand. Each reportable operating segment includes sales to wholesale and distributor customers, and sales through Company-owned retail stores and e-commerce activities based on the location of the selling entity.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.